Correct Option (A)
The passage explicitly identifies the lack of treatment for waste from antibiotics-manufacturing companies as a significant factor contributing to drug-resistant infections. The presence of drug-resistant bacteria near these plants underscores the environmental impact of untreated pharmaceutical effluent. Therefore, establishing proper effluent treatment protocols directly addresses the core issue highlighted, offering the most logical and practical solution to mitigate this environmental hazard and its public health consequences.
Incorrect Options:
Option (B): While environmental awareness is generally beneficial, the passage specifically focuses on the industrial practices of pharmaceutical companies and their waste management, rather than a broader call for public environmental awareness. The problem identified is industrial pollution, not a lack of public understanding.
Option (C): The passage does not suggest that the spread of drug-resistant bacteria is an unavoidable consequence inherent in modern medical care. Instead, it points to a specific, controllable environmental factor-untreated industrial waste-as a significant driver of this issue. This implies that the problem is manageable through appropriate interventions.
Option (D): Relocating pharmaceutical manufacturing companies to remote rural areas does not resolve the fundamental problem of untreated antibiotic waste. The core issue is the discharge of pollutants into the environment, which would persist regardless of the factory's location if proper treatment protocols are not implemented. The focus should be on waste treatment, not merely geographical displacement.